Exchange: NASDAQ·Updated 07:34 PM EDT
News
all
press releases
Caris Life Sciences,?Inc. (CAI) Reports Break-Even Earnings for Q2
Caris Life Sciences,?Inc. (CAI) delivered earnings and revenue surprises of +100.00% and +14.07%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday's after-market session. The company's market cap stands at $4.2 million. Caris Life Sciences (NASDAQ:CAI)read more...
Benzinga
Caris Life Sciences Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
Caris Life Sciences Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance Caris Life Sciences Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance PR Newswire IRVING, Texas, Aug. 5, 2026 Revenue growth of 45% driven by strong performance in...
PR Newswire
CareDx (CDNA) Beats Q2 Earnings and Revenue Estimates
CareDx (CDNA) delivered earnings and revenue surprises of +68.18% and +15.41%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026
Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026 Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026 PR Newswire IRVING, Texas, July 16, 2026 IRVING, Texas, July 16, 2026 /PRNewswire/ -- Caris Life Sciences (NASDAQ: CAI), a...
PR Newswire
Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing
Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing PR Newswire IRVING, Texas, July 14, 2026 IRVING, Texas, July 14, 2026 /PRNewswire/ -- Caris Life...
PR Newswire
Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test
Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test PR Newswire IRVING, Texas, July 1, 2026...
PR Newswire
Is Caris Life Sciences, Inc. (CAI) Stock Positioned for Growth With AI-Driven Precision Medicine Expansion?
Is Caris Life Sciences, Inc. (CAI) Stock Positioned for Growth With AI-Driven Precision Medicine Expansion...
Yahoo! Finance: News
Caris Life Sciences Announces Dual Listing on NYSE Texas
Caris Life Sciences Announces Dual Listing on NYSE Texas Caris Life Sciences Announces Dual Listing on NYSE Texas PR Newswire IRVING, Texas, June 16, 2026 IRVING, Texas, June 16, 2026 /PRNewswire/ -- Caris Life Sciences (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and...
PR Newswire
Caris Life Sciences Authorized Buy Back Up To $100 Mln
(RTTNews) - Caris Life Sciences (CAI), an AI TechBio company, Monday announced that it has been authorized to repurchase up to $100 million of the company's outstanding common stock...
Nasdaq News: Markets

Advertisement|Remove ads.